Multiple studies have shown that FABP5 is significantly overexpressed in HCC tissues compared to adjacent non-tumourous liver and correlates with aggressive clinical features, such as poor differentiation, microvascular invasion, larger tumour size, and reduced overall and disease-free survival [117,118,119,120]. Here, FABP5 is linked to hepatocellular carcinoma.